Search

Your search keyword '"Marc L. Citron"' showing total 20 results

Search Constraints

Start Over You searched for: Author "Marc L. Citron" Remove constraint Author: "Marc L. Citron" Search Limiters Full Text Remove constraint Search Limiters: Full Text
20 results on '"Marc L. Citron"'

Search Results

1. Measurement of differential tt¯ production cross sections in the full kinematic range using lepton+jets events from proton-proton collisions at s=13 TeV

2. Measurement of the top quark mass in the all-jets final state at $$\sqrt{s}=13\,\text {TeV} $$ s = 13 TeV and combination with the lepton+jets channel

3. Risk of acute myeloid leukemia and myelodysplastic syndrome among older women receiving anthracycline-based adjuvant chemotherapy for breast cancer on Modern Cooperative Group Trials (Alliance A151511)

4. Exploration of communication gaps among women with metastatic breast cancer, caregivers and oncologists

5. Understanding the Needs of Patients with Metastatic Breast Cancer: Results of the Make Your Dialogue Count Survey

6. Abstract P1-11-06: The experience of caregivers of women with metastatic breast cancer: Insights from the Make Your Dialogue Count survey

7. Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715)

8. Feasibility and Cardiac Safety of Trastuzumab Emtansine After Anthracycline-Based Chemotherapy As (neo)Adjuvant Therapy for Human Epidermal Growth Factor Receptor 2–Positive Early-Stage Breast Cancer

9. PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)

10. Abstract P2-15-03: Cardiac safety of trastuzumab emtansine (T-DM1) following anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive (HER2+) early-stage breast cancer (EBC): Final data from TDM4874g

11. Abstract P2-10-01: PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy

12. Dose-Dense Chemotherapy: Principles, Clinical Results and Future Perspectives

13. Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)

14. Predicting response and survival in chemotherapy-treated triple-negative breast cancer

15. Dihydro-5-azacytidine in malignant mesothelioma

16. Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York

17. Lung Cancer Risk in White and Black Americans

18. The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer

19. Estrogen-Receptor Status and Outcomes of Modern Chemotherapy for Patients With Node-Positive Breast Cancer

20. Improvement of human tumor cloning assay by suspension of fibroblasts into the bottom layer of agarose

Catalog

Books, media, physical & digital resources